Clinical

 

FDA Approves Vericiguat (Verquvo) for Treatment of Heart Failure

January 20, 2021

The US FDA has approved vericiguat (Verquvo) for reducing the risk of cardiovascular death and heart failure hospitalization following a hospitalization for heart failure or need for outpatient intravenous diuretics in patients with HFrEF.

Practicing Medicine in the Age of Misinformation with Gregory Weiss, MD

January 20, 2021

While social media and technology have allowed greater sharing of ideas and knowledge, they have also become a major source of misinformation. In this column, Dr. Weiss reflects on practicing during the age of misinformation.

Abdominal Aortic Calcification Tied to 80% Increase in Risk of CV Events, Death

January 18, 2021

Results from a systematic review and meta-analysis of more than 50 studies assessing cardiovascular risk with levels of abdominal aortic calcification indicate increased AAC was linked to 80% increase in risk of cardiovascular events and cardiovascular death.

One Drink Per Day Increases Risk of AFib 16% in Healthy Patients

January 14, 2021

An analysis of more than 100k people from five community-based cohorts indicates consuming one alcoholic drink per day could increase risk of atrial fibrillation by 16%, while consuming four per day increased risk by 47%.